Cargando…
Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors
Valosin-containing protein (VCP), together with several partner proteins, extracts ubiquitinated client proteins from E3 ligase complex and facilitates their degradation through ubiquitin–proteasome system. Therefore, it plays an important role in regulating protein quality control and various cellu...
Autores principales: | Bastola, Prabhakar, Wang, Feng, Schaich, Matthew A, Gan, Taiping, Freudenthal, Bret D, Chou, Tsui-Fen, Chien, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672561/ https://www.ncbi.nlm.nih.gov/pubmed/29367883 http://dx.doi.org/10.1038/cddiscovery.2017.65 |
Ejemplares similares
-
Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2018) -
Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019) -
Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain
por: Tang, Wai Kwan, et al.
Publicado: (2016) -
A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase
por: Segura-Cabrera, Aldo, et al.
Publicado: (2017) -
P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration
por: Wang, F, et al.
Publicado: (2022)